Aristocort FDA Approved Drugs
KENALOG [Triamcinolone AcetonideC24H31FO6]
RX
- 0.025% (topical ointment)
0.1% (topical ointment)
0.147mg/gm (topical spray)
Mylan Pharms IncApproved Prior To Jan 1, 1982
Ranbaxy Labs LtdApproved Prior To Jan 1, 1982
Ranbaxy Labs LtdApproved Prior To Jan 1, 1982
KENALOG-10 [Triamcinolone AcetonideC24H31FO6]
RX
- 10mg/ml (injection injectable)
ApotheconApproved Prior To Jan 1, 1982
KENALOG-40 [Triamcinolone AcetonideC24H31FO6]
RX
- 40mg/ml (injection injectable)
ApotheconApproved Prior To Jan 1, 1982
NASACORT ALLERGY 24 HOUR [Triamcinolone AcetonideC24H31FO6]
OTC
- 0.055mg/spray (nasal spray, metered)
Sanofi Aventis UsOct 11, 2013
- Treatment of nasal symptoms of seasonal and perennial allergic rhinitis in adults and children two years of age and older.
- Treatment of seasonal and perennial allergic rhinitis symptoms.
TRIAMCINOLONE ACETONIDE [Triamcinolone AcetonideC24H31FO6]
RX / OTC
- 0.025% (topical lotion)
0.055mg/spray (nasal spray, metered)
0.1% (dental paste)
0.147mg/gm (topical spray)
0.5% (topical ointment)
AkornMay 8, 2013
Fougera PharmsApproved Prior To Jan 1, 1982
G And W LabsDec 23, 1988
Lupin AtlantisFeb 1, 2017
Perrigo New YorkApproved Prior To Jan 1, 1982
Teligent Pharma IncJul 7, 2016
VintageJun 9, 2006
Wockhardt Eu OperatnApr 1, 1985
Mylan Pharms IncApproved Prior To Jan 1, 1982
Perrigo IsraelNov 14, 2014
G And W Labs IncAug 14, 1986
Glenmark Pharms LtdAug 5, 2016
LyneJul 1, 2010
TaroNov 26, 1997
Perrigo Uk FincoApr 13, 2015
Fougera PharmsApproved Prior To Jan 1, 1982
G And W LabsDec 23, 1988
Lupin AtlantisFeb 1, 2017
Perrigo New YorkApproved Prior To Jan 1, 1982
Teligent Pharma IncJul 7, 2016
VintageJun 9, 2006
Wockhardt Eu OperatnApr 1, 1985
Mylan Pharms IncApproved Prior To Jan 1, 1982
Perrigo IsraelNov 14, 2014
G And W Labs IncAug 14, 1986
Glenmark Pharms LtdAug 5, 2016
LyneJul 1, 2010
TaroNov 26, 1997
Perrigo Uk FincoApr 13, 2015
TRIAMCINOLONE ACETONIDE IN ABSORBASE [Triamcinolone AcetonideC24H31FO6]
RX
- 0.05% (topical ointment)
Cmp Pharma IncMar 23, 1995
TRIDERM [Triamcinolone AcetonideC24H31FO6]
RX
- 0.025% (topical cream)
0.1% (topical cream)
0.5% (topical cream)
Crown LabsMar 25, 2015
TRIESENCE [Triamcinolone AcetonideC24H31FO6]
RX
- 40mg/ml (40mg/ml) (intravitreal injectable)
Novartis Pharms CorpNov 29, 2007
- Treatment of ophthalmic disorders.
- Use for delineation (visualization) during a vitrectomy surgical procedure.
- Visualization during vitrectomy procedures.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.